Home Nucleus Healthcare U.S. Liver Cancer Diagnostics Market to 2032

U.S. Liver Cancer Diagnostics Market to 2032

Overview

The U.S. Liver Cancer Diagnostics Market is expected to reach a 4.40 USD Billion by 2032 and is projected to grow at a CAGR of 9.96% from 2025 to 2032.

Revenue, 2024 (USD Billion)
2.59
Forecast, 2032 (USD Billion)
4.40
CAGR, 2024 - 2032
9.96%
Report Coverage
U.S.

U.S. Liver Cancer Diagnostics Market 2018-2032 USD Billion

U.S. Liver Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 2.59 USD Billion
  • Projected Market Size (2032): 4.40 USD Billion
  • CAGR (2025-2032): 9.96%

Key Findings of U.S. Liver Cancer Diagnostics Market

  • The U.S. Liver Cancer Diagnostics Market was valued at 2.59 USD Billion in 2024.
  • The U.S. Liver Cancer Diagnostics Market is likely to grow at a CAGR of 9.96% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Male in Gender Segment accounted for the largest share of the market with a revenue of 1.76 USD Billion
  • The fastest growing segment Fluorescent In Situ Hybridization in Technology Segment grew Fastest with a CAGR of 12.45% during the forecast period from 2024 to 2032.

U.S. Liver Cancer Diagnostics Market Scope

U.S. Liver Cancer Diagnostics Market Segmentation & Scope
Technology
  • Others
  • Immunohistochemical
  • Comparative Genomic Hybridization
  • Fluoroimmunoassay
  • Next Generation Sequencing
  • Fluorescent In Situ Hybridization
Application
  • Research
  • Prognostic
  • Diagnostic and Predictive
  • Screening
Gender
  • Female
  • Male
End User
  • Others
  • Academic Institutes
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
Test Type
  •  Others
  • Biopsy
  • Genomic Test
  • Imaging Test
Cancer Stages
  • Stage 0
  • Stage I
  • Stage IV
  • Stage II
  • Stage III
Cancer Type
  • Primary Liver Cancer
  • Secondary Liver Cancer
Product
  • Other Consumables
  • Kits & Reagents
  • Instrument-Based Products
  • Platform-Based Products

U.S. Liver Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 2.59 USD Billion
Market Value in 2032 4.40 USD Billion
CAGR (2025-2032) 9.96%
Historic Data 2016-2023
Market Segments Covered Technology,Application,Gender,End User,Distribution Channel, Test Type,Cancer Stages,Cancer Type,Product

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 2.59 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 2,587.19 USD Million in 2024.

Segments and Scope

  • U.S. Liver Cancer Diagnostics Market to 2032, By Technology
    • Fluorescent In Situ Hybridization is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 865.22 USD Billion in the year 2024.
    • Fluorescent In Situ Hybridization is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 12.45 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Application
    • Screening is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.40 USD Billion in the year 2024.
    • Screening is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 11.21 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Gender
    • Male is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.76 USD Billion in the year 2024.
    • Male is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 10.33 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.01 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 12.34 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.37 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 11.43 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Test Type
    • Imaging Test is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.28 USD Billion in the year 2024.
    • Genomic Test is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 10.56 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Cancer Stages
    • Stage III is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.12 USD Billion in the year 2024.
    • Stage III is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 10.59 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Cancer Type
    • Secondary Liver Cancer is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.67 USD Billion in the year 2024.
    • Secondary Liver Cancer is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 10.35 % in forecast period 2025-2032.
  • U.S. Liver Cancer Diagnostics Market to 2032, By Product
    • Platform-Based Products is the largest segment in U.S. Liver Cancer Diagnostics Market to 2032 with a revenue of 1.29 USD Billion in the year 2024.
    • Platform-Based Products is the Fastest growing segment in U.S. Liver Cancer Diagnostics Market to 2032 with a Growth rate of 11.45 % in forecast period 2025-2032.

U.S. Liver Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
KoninKlijke Philips N.V.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
U.S. Liver Cancer Diagnostics Market Company Share Analysis

U.S. Liver Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Liver Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Liver Cancer Diagnostics Market Company Profiling

U.S. Liver Cancer Diagnostics Market Company Profiling

Industry Related Reports

Asia-Pacific Discharge Inks Market for Textile Industry Market
Europe Discharge Inks Market for Textile Industry Market
North America Discharge Inks Market for Textile Industry Market
Middle East & Africa Discharge Inks Market for Textile Industry Market
South America Discharge Inks Market for Textile Industry Market
United Arab Emirates Discharge Inks Market for Textile Industry Market
Argentina Discharge Inks Market for Textile Industry Market
Australia Discharge Inks Market for Textile Industry Market
Belgium Discharge Inks Market for Textile Industry Market
Brazil Discharge Inks Market for Textile Industry Market
Frequently Asked Questions
The U.S. Liver Cancer Diagnostics Market is segmented based on Segmentation Technology,Application,Gender,End User,Distribution Channel, Test Type,Cancer Stages,Cancer Type,Product.
U.S. Liver Cancer Diagnostics Market was valued at USD 2.59(Revenue in USD Billion) in 2021.
U.S. Liver Cancer Diagnostics Market is projected to grow at a CAGR of 9.96% during the forecast period of 2024 to 2032.
The Male segment is expected to dominate the U.S. Liver Cancer Diagnostics Market, holding a largest market share of 1.76 USD Billion in 2024

U.S. Liver Cancer Diagnostics Market Scope

U.S. Liver Cancer Diagnostics Market Segmentation & Scope
Technology
  • Others
  • Immunohistochemical
  • Comparative Genomic Hybridization
  • Fluoroimmunoassay
  • Next Generation Sequencing
  • Fluorescent In Situ Hybridization
Application
  • Research
  • Prognostic
  • Diagnostic and Predictive
  • Screening
Gender
  • Female
  • Male
End User
  • Others
  • Academic Institutes
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
Test Type
  •  Others
  • Biopsy
  • Genomic Test
  • Imaging Test
Cancer Stages
  • Stage 0
  • Stage I
  • Stage IV
  • Stage II
  • Stage III
Cancer Type
  • Primary Liver Cancer
  • Secondary Liver Cancer
Product
  • Other Consumables
  • Kits & Reagents
  • Instrument-Based Products
  • Platform-Based Products
Frequently Asked Questions
The U.S. Liver Cancer Diagnostics Market is segmented based on Segmentation Technology,Application,Gender,End User,Distribution Channel, Test Type,Cancer Stages,Cancer Type,Product.
U.S. Liver Cancer Diagnostics Market was valued at USD 2.59(Revenue in USD Billion) in 2021.
U.S. Liver Cancer Diagnostics Market is projected to grow at a CAGR of 9.96% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Liver Cancer Diagnostics Market for final year is USD 4.40 (USD Billion).

U.S. Liver Cancer Diagnostics Market Company Profiling

U.S. Liver Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.S. Liver Cancer Diagnostics Market is segmented based on Segmentation Technology,Application,Gender,End User,Distribution Channel, Test Type,Cancer Stages,Cancer Type,Product.
U.S. Liver Cancer Diagnostics Market was valued at USD 2.59(Revenue in USD Billion) in 2021.
U.S. Liver Cancer Diagnostics Market is projected to grow at a CAGR of 9.96% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Liver Cancer Diagnostics Market for final year is USD 4.40 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES